Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit

Rhea-AI Summary

Oragenics Inc. (NYSE American: OGEN), a company focused on developing new treatments for brain-related health conditions, has announced its participation in the Centurion One Capital 2nd Annual Bahamas Summit. The event will take place at the Rosewood Baha Mar Hotel in Nassau, Bahamas on October 22-23, 2024.

Michael Redmond, President of Oragenics, is scheduled to deliver a corporate presentation and participate in a Q&A session on October 22, 2024, at 1:20 pm ET. This presentation offers an opportunity for investors and interested parties to gain insights into Oragenics' current projects and future plans in the field of brain health treatments.

Attendees can register for the event through a provided link, allowing them to participate in this significant gathering of industry professionals and potential investors in the pharmaceutical and biotechnology sectors.

News Market Reaction

+0.34%

1 alert

+0.34% News Effect

On the day this news was published, OGEN gained 0.34%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

SARASOTA, Fla., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Oragenics Inc. (NYSE American: OGEN), a company focused on developing new treatments for brain-related health conditions, announced it will be presenting at the Centurion One Capital 2nd Annual Bahamas Summit to be held at the Rosewood Baha Mar Hotel on October 22-23, 2024, in Nassau, Bahamas. Michael Redmond, President of Oragenics, will participate in a corporate presentation and Q&A session on October 22, 2024 at 1:20 pm ET.

Details for the presentation are as follows:
Date: Tuesday, October 22, 2024
Time: 1:20 p.m. EDT
Presenter: Michael Redmond, President of Oragenics
Register for the event by clicking here.

About Oragenics:

Oragenics is a development-stage biotechnology company focused on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating mild traumatic brain injury (mTBI), also known as concussion, and for treating Niemann Pick Disease Type C (NPC), as well as proprietary powder formulation and an intranasal delivery device. For more information, please visit www.oragenics.com.

Investor Relations:
Rich Cockrell
CG Capital
404-736-3838
ogen@cg.capital

FAQ

When and where is Oragenics (OGEN) presenting at the Centurion One Capital Bahamas Summit?

Oragenics (OGEN) is presenting at the Centurion One Capital 2nd Annual Bahamas Summit on Tuesday, October 22, 2024, at 1:20 p.m. EDT. The event is being held at the Rosewood Baha Mar Hotel in Nassau, Bahamas.

Who will be representing Oragenics (OGEN) at the Centurion One Capital Bahamas Summit?

Michael Redmond, President of Oragenics, will be representing the company at the Centurion One Capital 2nd Annual Bahamas Summit. He will deliver a corporate presentation and participate in a Q&A session.

What is the focus of Oragenics (OGEN) as mentioned in the press release?

According to the press release, Oragenics (OGEN) is a company focused on developing new treatments for brain-related health conditions.

How can interested parties attend Oragenics' (OGEN) presentation at the Centurion One Capital Bahamas Summit?

Interested parties can register for the event by clicking on a link provided in the press release. This will allow them to attend Oragenics' (OGEN) presentation at the Centurion One Capital 2nd Annual Bahamas Summit.